2020 Q4 Form 10-Q Financial Statement

#000106505920000047 Filed on November 13, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q4
Revenue $92.90M $33.60M $55.70M
YoY Change 66.79% -67.91% -33.53%
Cost Of Revenue $57.90M $34.40M $48.90M
YoY Change 18.4% -50.29% -47.7%
Gross Profit $35.00M -$800.0K $6.800M
YoY Change 414.71% -102.25% -170.1%
Gross Profit Margin 37.67% -2.38% 12.21%
Selling, General & Admin $10.40M $6.700M $9.200M
YoY Change 13.04% -22.99% -9.8%
% of Gross Profit 29.71% 135.29%
Research & Development $1.000M $200.0K $1.600M
YoY Change -37.5% -84.62% -76.81%
% of Gross Profit 2.86% 23.53%
Depreciation & Amortization $2.600M $1.300M $2.500M
YoY Change 4.0% -31.58% 8.7%
% of Gross Profit 7.43% 36.76%
Operating Expenses $11.40M $6.900M $10.80M
YoY Change 5.56% -31.0% -36.84%
Operating Profit $20.60M -$9.500M -$6.700M
YoY Change -407.46% -141.13% -77.36%
Interest Expense $0.00 $100.0K $200.0K
YoY Change -100.0% -125.0% -140.0%
% of Operating Profit 0.0%
Other Income/Expense, Net -$5.000M $2.200M $4.100M
YoY Change -221.95% 2100.0% -126.45%
Pretax Income $15.60M -$7.200M -$2.400M
YoY Change -750.0% -131.58% -94.68%
Income Tax -$800.0K -$200.0K $400.0K
% Of Pretax Income -5.13%
Net Earnings $16.40M -$7.000M -$2.800M
YoY Change -685.71% -130.7% -93.81%
Net Earnings / Revenue 17.65% -20.83% -5.03%
Basic Earnings Per Share -$2.55 -$0.83 -$0.49
Diluted Earnings Per Share -$2.55 -$0.83 -$0.49
COMMON SHARES
Basic Shares Outstanding 11.32M shares 10.72M shares 9.457M shares
Diluted Shares Outstanding 10.72M shares

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $152.0M $152.8M $130.7M
YoY Change 16.3% 97.93% 6.17%
Cash & Equivalents $152.0M $152.8M $130.7M
Short-Term Investments
Other Short-Term Assets $7.800M $7.400M $9.200M
YoY Change -15.22% -70.98% -74.86%
Inventory $64.80M $66.60M $64.50M
Prepaid Expenses
Receivables $29.60M $14.10M $21.10M
Other Receivables $23.00M $6.000M $0.00
Total Short-Term Assets $406.1M $386.3M $369.6M
YoY Change 9.88% 6.39% -23.72%
LONG-TERM ASSETS
Property, Plant & Equipment $4.900M $4.400M $3.700M
YoY Change 32.43% 15.79% -11.9%
Goodwill
YoY Change
Intangibles $62.80M $65.20M $69.50M
YoY Change -9.64% -9.32% -8.55%
Long-Term Investments
YoY Change
Other Assets $4.900M $6.600M $7.400M
YoY Change -33.78% -1.49% 957.14%
Total Long-Term Assets $80.20M $81.90M $86.30M
YoY Change -7.07% -7.04% -1.03%
TOTAL ASSETS
Total Short-Term Assets $406.1M $386.3M $369.6M
Total Long-Term Assets $80.20M $81.90M $86.30M
Total Assets $486.3M $468.2M $455.9M
YoY Change 6.67% 3.77% -20.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.30M $0.00 $8.100M
YoY Change 162.96% -100.0% -82.39%
Accrued Expenses $50.60M $52.20M $50.70M
YoY Change -0.2% 2510.0%
Deferred Revenue $283.2M $249.7M $266.3M
YoY Change 6.35% 971.67%
Short-Term Debt $0.00 $0.00 $6.100M
YoY Change -100.0% -100.0% -81.4%
Long-Term Debt Due $6.100M $6.100M $6.100M
YoY Change 0.0% 0.0% -81.4%
Total Short-Term Liabilities $366.1M $315.8M $336.8M
YoY Change 8.7% -4.62% -23.23%
LONG-TERM LIABILITIES
Long-Term Debt $108.0M $108.0M $114.1M
YoY Change -5.35% -5.35% -5.07%
Other Long-Term Liabilities $32.40M $22.60M $32.10M
YoY Change 0.93% -0.44% 119.86%
Total Long-Term Liabilities $32.40M $22.60M $792.8M
YoY Change -95.91% -97.13% -11.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $366.1M $315.8M $336.8M
Total Long-Term Liabilities $32.40M $22.60M $792.8M
Total Liabilities $806.9M $743.8M $792.8M
YoY Change 1.78% -33.45% -40.49%
SHAREHOLDERS EQUITY
Retained Earnings -$407.7M -$367.0M -$405.0M
YoY Change 0.67% -8.75% 4.25%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$320.6M -$275.6M -$336.9M
YoY Change
Total Liabilities & Shareholders Equity $486.3M $468.2M $455.9M
YoY Change 6.67% 3.77% -20.26%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q4
OPERATING ACTIVITIES
Net Income $16.40M -$7.000M -$2.800M
YoY Change -685.71% -130.7% -93.81%
Depreciation, Depletion And Amortization $2.600M $1.300M $2.500M
YoY Change 4.0% -31.58% 8.7%
Cash From Operating Activities $61.90M $13.60M $37.80M
YoY Change 63.76% -26.88% 1045.45%
INVESTING ACTIVITIES
Capital Expenditures -$500.0K -$800.0K -$100.0K
YoY Change 400.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$500.0K -$800.0K -$100.0K
YoY Change 400.0% -500.0% -200.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -62.20M 20.70M -1.200M
YoY Change 5083.33% -167.43% -76.0%
NET CHANGE
Cash From Operating Activities 61.90M 13.60M 37.80M
Cash From Investing Activities -500.0K -800.0K -100.0K
Cash From Financing Activities -62.20M 20.70M -1.200M
Net Change In Cash -800.0K 33.50M 36.50M
YoY Change -102.19% -381.51% -2381.25%
FREE CASH FLOW
Cash From Operating Activities $61.90M $13.60M $37.80M
Capital Expenditures -$500.0K -$800.0K -$100.0K
Free Cash Flow $62.40M $14.40M $37.90M
YoY Change 64.64% -22.58% 1048.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
CENTRUS ENERGY CORP
dei Entity Central Index Key
EntityCentralIndexKey
0001065059
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11320689 shares
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Shell Company
EntityShellCompany
false
dei Entity File Number
EntityFileNumber
1-14287
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-2107911
dei Entity Address Address Line1
EntityAddressAddressLine1
6901 Rockledge Drive, Suite 800
dei Entity Address City Or Town
EntityAddressCityOrTown
Bethesda
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20817
dei City Area Code
CityAreaCode
301
dei Local Phone Number
LocalPhoneNumber
564-3200
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2500000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2200000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
152800000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
130700000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14100000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21100000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
66600000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
64500000 USD
CY2020Q3 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
145400000 USD
CY2019Q4 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
144100000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7400000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9200000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
386300000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
369600000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4400000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3700000 USD
CY2020Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
5700000 USD
CY2019Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
5700000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
65200000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
69500000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6600000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7400000 USD
CY2020Q3 us-gaap Assets
Assets
468200000 USD
CY2019Q4 us-gaap Assets
Assets
455900000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
52200000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
50700000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
0 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8100000 USD
CY2020Q3 leu Inventories Owed To Customers And Suppliers
InventoriesOwedToCustomersAndSuppliers
7800000 USD
CY2019Q4 leu Inventories Owed To Customers And Suppliers
InventoriesOwedToCustomersAndSuppliers
5600000 USD
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
249700000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
266300000 USD
CY2020Q3 us-gaap Debt Current
DebtCurrent
6100000 USD
CY2019Q4 us-gaap Debt Current
DebtCurrent
6100000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
315800000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
336800000 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
108000000.0 USD
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
114100000 USD
CY2020Q3 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
131300000 USD
CY2019Q4 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
138600000 USD
CY2020Q3 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
121200000 USD
CY2019Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
141800000 USD
CY2020Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
44900000 USD
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
29400000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
22600000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
32100000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
743800000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
792800000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
84800000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
61500000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-367000000.0 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
104700000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-405000000.0 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
800000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1100000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-275600000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-336900000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
468200000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
455900000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
33600000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
154300000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
154000000.0 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
34400000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
69200000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
91700000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
128300000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
-800000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
35500000 USD
us-gaap Gross Profit
GrossProfit
62600000 USD
us-gaap Gross Profit
GrossProfit
25700000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
200000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1300000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1800000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13000000.0 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6700000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8700000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
25600000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24500000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000 USD
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1800000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4300000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4100000 USD
CY2020Q3 us-gaap Restructuring Charges
RestructuringCharges
600000 USD
CY2019Q3 us-gaap Restructuring Charges
RestructuringCharges
800000 USD
us-gaap Restructuring Charges
RestructuringCharges
500000 USD
us-gaap Restructuring Charges
RestructuringCharges
-2200000 USD
CY2020Q3 leu Gain On Sales Of Assets
GainOnSalesOfAssets
0 USD
CY2019Q3 leu Gain On Sales Of Assets
GainOnSalesOfAssets
-200000 USD
leu Gain On Sales Of Assets
GainOnSalesOfAssets
0 USD
leu Gain On Sales Of Assets
GainOnSalesOfAssets
-700000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9500000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
23100000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
30400000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-13000000.0 USD
CY2020Q3 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-2200000 USD
CY2019Q3 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-100000 USD
us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-6600000 USD
us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-200000 USD
CY2020Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
0 USD
CY2019Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
900000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
100000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
2900000 USD
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
100000 USD
CY2019Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
500000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
500000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
1900000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-7200000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
22800000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
37400000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-13800000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-200000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-600000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-100000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-7000000.0 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
22800000 USD
us-gaap Net Income Loss
NetIncomeLoss
38000000.0 USD
us-gaap Net Income Loss
NetIncomeLoss
-13700000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10723000 shares
CY2020Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1900000 USD
CY2019Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1900000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5900000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5900000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8900000 USD
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
20900000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
32100000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19600000 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.83
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.05
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.83
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.05
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9582000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10008000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9560000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10723000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9626000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10282000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9560000 shares
us-gaap Net Income Loss
NetIncomeLoss
38000000.0 USD
us-gaap Net Income Loss
NetIncomeLoss
-13700000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4700000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4500000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
0 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
1100000 USD
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
0 USD
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
700000 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
0 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
2300000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7000000.0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-31300000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-17100000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9300000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-300000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-11200000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-8100000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-33000000.0 USD
leu Increase Decreasein Deferred Revenue Netof Deferred Costs
IncreaseDecreaseinDeferredRevenueNetofDeferredCosts
-17500000 USD
leu Increase Decreasein Deferred Revenue Netof Deferred Costs
IncreaseDecreaseinDeferredRevenueNetofDeferredCosts
18900000 USD
leu Accruedlossonlongtermcontractincreasedecrease
Accruedlossonlongtermcontractincreasedecrease
-8700000 USD
us-gaap Loss On Contracts
LossOnContracts
0 USD
us-gaap Increase Decrease In Pension Plan Obligations
IncreaseDecreaseInPensionPlanObligations
-28100000 USD
us-gaap Increase Decrease In Pension Plan Obligations
IncreaseDecreaseInPensionPlanObligations
-15900000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-1100000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
800000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5200000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26500000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
900000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
700000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-900000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
700000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
23800000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
200000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
27500000 USD
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
100000 USD
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
200000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
6100000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
6100000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17800000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-33800000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
22100000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-59600000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
136600000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
159700000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
158700000 USD
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
100100000 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
1500000 USD
us-gaap Notes Issued1
NotesIssued1
0 USD
us-gaap Notes Issued1
NotesIssued1
700000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-321900000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-20900000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
100000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-342700000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-325400000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-15600000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-358300000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
22800000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
100000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-335400000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-336900000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
11300000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
200000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
33700000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-291700000 USD
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
23100000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-7000000.0 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-275600000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
32400000 USD
CY2020Q3 us-gaap Billed Contract Receivables
BilledContractReceivables
6000000.0 USD
CY2019Q4 us-gaap Billed Contract Receivables
BilledContractReceivables
13200000 USD
CY2020Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
8100000 USD
CY2019Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
7900000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14100000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21100000 USD
leu Provision For Loss On Contract Change
ProvisionForLossOnContractChange
-1100000 USD
leu Provision For Loss On Contract Noncurrent Change
ProvisionForLossOnContractNoncurrentChange
-7600000 USD
CY2020Q3 us-gaap Deferred Revenue
DeferredRevenue
248200000 USD
CY2019Q4 us-gaap Deferred Revenue
DeferredRevenue
243000000.0 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5200000 USD
CY2020Q3 leu Advancesfromcustomerscurrent
Advancesfromcustomerscurrent
1500000 USD
CY2019Q4 leu Advancesfromcustomerscurrent
Advancesfromcustomerscurrent
23300000 USD
us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
-21800000 USD
CY2020Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
44900000 USD
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
29400000 USD
leu Increasedecreasein Advancesfromcustomersnoncurrent
IncreasedecreaseinAdvancesfromcustomersnoncurrent
15500000 USD
us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
5200000 USD
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
5200000 USD
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
5200000 USD
CY2020Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1000000000.0 USD
CY2020Q3 leu Deferred Revenue And Advances From Customers Approximate
DeferredRevenueAndAdvancesFromCustomersApproximate
300000000 USD
us-gaap Nonmonetary Transaction Gross Operating Revenue Recognized
NonmonetaryTransactionGrossOperatingRevenueRecognized
23400000 USD
us-gaap Nonmonetary Transaction Amount Of Barter Transaction
NonmonetaryTransactionAmountOfBarterTransaction
44400000 USD
CY2020Q2 us-gaap Nonmonetary Transaction Amount Of Barter Transaction
NonmonetaryTransactionAmountOfBarterTransaction
15000000.0 USD
CY2020Q1 leu Separative Work Units Owed To Others New Borrowings
SeparativeWorkUnitsOwedToOthersNewBorrowings
1700000 USD
CY2020Q3 leu Provision For Loss On Contracts Utilized
ProvisionForLossOnContractsUtilized
3400000 USD
leu Provision For Loss On Contracts Utilized
ProvisionForLossOnContractsUtilized
8700000 USD
CY2020Q3 leu Governmentcostobligation
Governmentcostobligation
74500000 USD
CY2020Q3 leu Separativeworkunitsowedtoothersnoncurrent
Separativeworkunitsowedtoothersnoncurrent
10800000 USD
CY2020Q3 leu Provision For Loss On Contracts Total
ProvisionForLossOnContractsTotal
9600000 USD
CY2020Q3 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
8900000 USD
CY2020Q3 leu Provisionforlossoncontractsnoncurrent
Provisionforlossoncontractsnoncurrent
700000 USD
us-gaap Restructuring Charges
RestructuringCharges
500000 USD
us-gaap Severance Costs1
SeveranceCosts1
600000 USD
us-gaap Restructuring Reserve Settled Without Cash2
RestructuringReserveSettledWithoutCash2
100000 USD
CY2019Q4 us-gaap Restructuring Reserve
RestructuringReserve
1400000 USD
us-gaap Restructuring Charges
RestructuringCharges
500000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
1200000 USD
CY2020Q3 us-gaap Restructuring Reserve
RestructuringReserve
700000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
152800000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
130700000 USD
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
200000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
200000 USD
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5700000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5700000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
158700000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
136600000 USD
CY2020Q3 leu Separative Work Units Inventory
SeparativeWorkUnitsInventory
10100000 USD
CY2020Q3 leu Separative Work Units Owed To Customers And Suppliers
SeparativeWorkUnitsOwedToCustomersAndSuppliers
3100000 USD
CY2020Q3 leu Separative Work Units Net Of Liability
SeparativeWorkUnitsNetOfLiability
7000000.0 USD
CY2019Q4 leu Separative Work Units Inventory
SeparativeWorkUnitsInventory
7800000 USD
CY2019Q4 leu Separative Work Units Owed To Customers And Suppliers
SeparativeWorkUnitsOwedToCustomersAndSuppliers
0 USD
CY2019Q4 leu Separative Work Units Net Of Liability
SeparativeWorkUnitsNetOfLiability
7800000 USD
CY2020Q3 leu Uranium Inventory
UraniumInventory
56500000 USD
CY2020Q3 leu Uranium Owed To Customers And Suppliers
UraniumOwedToCustomersAndSuppliers
4700000 USD
CY2020Q3 leu Uranium Inventory Net Of Liability
UraniumInventoryNetOfLiability
51800000 USD
CY2019Q4 leu Uranium Inventory
UraniumInventory
56700000 USD
CY2019Q4 leu Uranium Owed To Customers And Suppliers
UraniumOwedToCustomersAndSuppliers
5600000 USD
CY2019Q4 leu Uranium Inventory Net Of Liability
UraniumInventoryNetOfLiability
51100000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
66600000 USD
CY2020Q3 leu Inventories Owed To Customers And Suppliers
InventoriesOwedToCustomersAndSuppliers
7800000 USD
CY2020Q3 leu Inventory Net Of Liability
InventoryNetOfLiability
58800000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
64500000 USD
CY2019Q4 leu Inventories Owed To Customers And Suppliers
InventoriesOwedToCustomersAndSuppliers
5600000 USD
CY2019Q4 leu Inventory Net Of Liability
InventoryNetOfLiability
58900000 USD
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P15Y
CY2019Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
130700000 USD
CY2020Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
123500000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
58300000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
65200000 USD
CY2019Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
123500000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
54000000.0 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
69500000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
152800000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
152800000 USD
CY2019Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1900000 USD
CY2020Q3 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
2200000 USD
CY2019Q4 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
1800000 USD
CY2020Q3 us-gaap Fair Value Liabilities Measured On Recurring Basis Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisObligations
2100000 USD
CY2019Q4 us-gaap Fair Value Liabilities Measured On Recurring Basis Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisObligations
1800000 USD
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
800000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-7000000.0 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
22800000 USD
us-gaap Net Income Loss
NetIncomeLoss
38000000.0 USD
us-gaap Net Income Loss
NetIncomeLoss
-13700000 USD
CY2020Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1900000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5900000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5900000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8900000 USD
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
20900000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
32100000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19600000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10723000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9582000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10008000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9560000 shares
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2019Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
44000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
274000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10723000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9626000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10282000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9560000 shares
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.83
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.05
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.83
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.05
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
317000 shares
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
67000 shares
CY2020Q3 leu Options With Exercise Price Greater Than Market Price
OptionsWithExercisePriceGreaterThanMarketPrice
0 shares
CY2019Q3 leu Options With Exercise Price Greater Than Market Price
OptionsWithExercisePriceGreaterThanMarketPrice
460000 shares
leu Options With Exercise Price Greater Than Market Price
OptionsWithExercisePriceGreaterThanMarketPrice
0 shares
leu Options With Exercise Price Greater Than Market Price
OptionsWithExercisePriceGreaterThanMarketPrice
460000 shares
CY2020Q3 us-gaap Gain Contingency Unrecorded Amount
GainContingencyUnrecordedAmount
42800000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33600000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
104700000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
154300000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
154000000.0 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
-800000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
35500000 USD
us-gaap Gross Profit
GrossProfit
62600000 USD
us-gaap Gross Profit
GrossProfit
25700000 USD
CY2020Q3 leu Preferred Stock Tender Offer Maximum
PreferredStockTenderOfferMaximum
60000000 USD
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2020Q3 leu Preferred Stock Tender Offer Per Share
PreferredStockTenderOfferPerShare
954.59
CY2020Q3 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
1272.78
CY2020Q3 leu Preferred Stock Tender Offer Maximum
PreferredStockTenderOfferMaximum
60000000 USD
CY2020Q3 leu Preferred Stock Tender Offer Maximum Shares
PreferredStockTenderOfferMaximumShares
62854 shares

Files In Submission

Name View Source Status
0001065059-20-000047-index-headers.html Edgar Link pending
0001065059-20-000047-index.html Edgar Link pending
0001065059-20-000047.txt Edgar Link pending
0001065059-20-000047-xbrl.zip Edgar Link pending
exhibit10-120200930.htm Edgar Link pending
exhibit31-120200930.htm Edgar Link pending
exhibit31-220200930.htm Edgar Link pending
exhibit32-120200930.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
leu-20200930.htm Edgar Link pending
leu-20200930.xsd Edgar Link pending
leu-20200930_cal.xml Edgar Link unprocessable
leu-20200930_def.xml Edgar Link unprocessable
leu-20200930_g1.jpg Edgar Link pending
leu-20200930_htm.xml Edgar Link completed
leu-20200930_lab.xml Edgar Link unprocessable
leu-20200930_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending